LOS ANGELES, Nov 7 (Reuters) - Early results from an ongoing study showed that people with newly diagnosed rheumatoid arthritis were more likely to reach clinical remission with Amgen Inc and Wyeth's ...
THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., June 20, 2003 – Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced results of a new study assessing the ...
THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...
Combining a new drug with the standard initial treatment for rheumatoid arthritis seems to work better than using either medicine alone, research indicates. About 1 percent of people have rheumatoid ...
SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
COLLEGEVILLE, Pa., and THOUSAND OAKS, Calif. A study has found that when given early in the onset of rheumatoid arthritis in combination with other therapies, Amgen’s drug Enbrel (etanercept) can ...
Please provide your email address to receive an email when new articles are posted on . Methotrexate increases the probability of remission with adalimumab or infliximab by 50% in patients with ...
Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...
KENILWORTH, N.J. & SEOUL, South Korea--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced that pivotal Phase 3 clinical studies of SB4, ...
I just had an interesting experience with CVS Caremark. A few days ago, I saw a patient who had failed both Remicade® and Xeljanz® (she received the latter in a clinical trial at my practice). Given ...
WILMINGTON, Del., Oct 28 (Reuters) - A British charitable trust filed a patent infringement suit against Wyeth and Amgen on Wednesday over their blockbuster Enbrel drug, one of the world's ...
The FINANCIAL — Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. on June 10 announced that pivotal Phase 3 clinical studies of SB4, an investigational biosimilar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results